4.7 Review

Current Insight into the Role of IL-35 and Its Potential Involvement in the Pathogenesis and Therapy of Atopic Dermatitis

Related references

Note: Only part of the references are listed.
Article Allergy

IL-35 and IL-37 are negatively correlated with high IgE production among children with asthma in Saudi Arabia

Amir Abushouk et al.

Summary: The study revealed significantly elevated levels of IgE and multiple cytokines in patients with asthma, with IL-1 beta, IL-4, IL-10, and IL-13 showing positive correlations with IgE, and IL-35 and IL-37 showing negative correlations with IgE.

JOURNAL OF ASTHMA (2022)

Review Allergy

Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors

Chisa Nakashima et al.

Summary: Atopic dermatitis is a chronic, eczematous skin condition characterized by severe itchiness. Th2 cell-mediated immunity, skin barrier dysfunction, and pruritus contribute to the development of atopic dermatitis. The JAK/STAT pathway is involved in various inflammatory diseases, including atopic dermatitis. JAK inhibitors show promise as potential treatments for severe atopic dermatitis.

ALLERGOLOGY INTERNATIONAL (2022)

Article Biotechnology & Applied Microbiology

Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy

Ai Yan et al.

Summary: IL-35 protects against proliferative diabetic retinopathy by reducing IL-17 levels and inhibiting Th17 cell differentiation.

BIOENGINEERED (2022)

Review Pediatrics

Expression of Helper and Regulatory T Cells in Atopic Dermatitis: A Meta-Analysis

Dao-Jun Zhang et al.

Summary: The meta-analysis showed that patients with AD have increased levels of Th22 cells, Th17 cells, and IL-17, while having decreased levels of Tregs in peripheral blood. This suggests that Th22 cells, Th17 cells, IL-17, and Tregs may be involved in the pathogenesis of AD.

FRONTIERS IN PEDIATRICS (2022)

Article Biochemistry & Molecular Biology

Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Zhengkang Luo et al.

Summary: Macrophages play an important role in the early development of type 1 diabetes (T1D). This study investigated the M1 and M2 macrophages in the early development of T1D and found that IL-35 treatment reduced the proportion of pro-inflammatory macrophages and increased the proportion of anti-inflammatory macrophages, leading to lower blood glucose levels. These findings suggest that IL-35 may be a potential treatment for T1D and other autoimmune disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Photoreceptor Cells Constitutively Express IL-35 and Promote Ocular Immune Privilege

Cheng-Rong Yu et al.

Summary: Interleukin-27 (IL-27) and Interleukin-35 (IL-35) have different roles in neuroinflammation and uveitis. IL-27 can suppress encephalomyelitis and autoimmune uveitis, while IL-35 may have a protective role in the retina by constitutive secretion to counteract persistent low-grade inflammation. Decreased expression of IL-35 leads to increased severity of uveitis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Dermatology

Pro-inflammatory versus anti-inflammatory cytokines in psoriatic patients (case-control study)

Amaal Mohamed Elbana et al.

Summary: This study investigated the association between inflammatory and anti-inflammatory cytokines in psoriasis patients. The results showed that IL-35 plays a significant role in the pathogenetic process of psoriasis and could be used as a potential therapeutic agent in the future.

JOURNAL OF COSMETIC DERMATOLOGY (2022)

Article Dermatology

Pro-Inflammatory versus Anti-Inflammatory cytokines in atopic dermatitis patients: A case control study

Azza Hamada Kiwan et al.

Summary: This study aimed to investigate the association between inflammatory cytokines and anti-inflammatory cytokines in patients with atopic dermatitis (AD). The results showed that the levels of inflammatory cytokines were higher and the levels of anti-inflammatory cytokines were lower in AD patients. Furthermore, there was a significant correlation between the inflammatory cytokines and disease severity. The findings could serve as clues for the development of diagnostic biomarkers for AD severity and suggest a potential future treatment using IL-17 blockers.

JOURNAL OF COSMETIC DERMATOLOGY (2022)

Review Medicine, General & Internal

Interleukin-35 in autoimmune dermatoses: Current concepts

Yuming Xie et al.

Summary: IL-35 is a cytokine that regulates the functions of immune cells. It has been found to play an important role in autoimmune dermatoses and may serve as a therapeutic target.

OPEN MEDICINE (2022)

Article Allergy

Inhibited interleukin 35 expression and interleukin 35-induced regulatory T cells promote type II innate lymphoid cell response in allergic rhinitis

Wenlong Liu et al.

Summary: The study suggests that IL-35 can help alleviate allergic rhinitis by inhibiting ILC2 responses directly or indirectly, highlighting IL-35 as a potential therapeutic target.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Interleukin 35 Regulatory B Cells

Jin Kyeong Choi et al.

Summary: B lymphocytes play a central role in host immunity by orchestrating humoral immune responses and producing neutralizing antibodies. Recent recognition shows that B cells also help maintain peripheral tolerance and suppress autoimmune diseases, with rare populations of regulatory B cells producing anti-inflammatory cytokines. The newly discovered i35-Bregs can suppress autoimmune diseases by inducing infectious tolerance in conventional B cells.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Review Allergy

New treatments in atopic dermatitis

Neha Puar et al.

Summary: The review discusses the efficacy and safety of novel and emerging topical and systemic therapeutic agents for atopic dermatitis, highlighting the new drugs currently in clinical trials and future directions. It emphasizes the need to develop new targeted therapies for effective management of atopic dermatitis and outlines future research focus areas in developing predictive models for personalized management options.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

TSLP as druggable target - a silver-lining for atopic diseases?

Partho Protim Adhikary et al.

Summary: Atopic diseases such as atopic dermatitis, allergic rhinitis, and allergic asthma are common allergic inflammatory diseases. Thymic stromal lymphopoietin (TSLP) plays a key role in regulating tissue microenvironment and driving atopic diseases.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Rheumatology

Interleukin-35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases

Di Wang et al.

Summary: IL-35 plays a crucial role in regulating the balance of Th17/Treg responses, and abnormal IL-35 expression may lead to the development and progression of various connective tissue diseases.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Review Immunology

The Role of Regulatory B Cells in Health and Diseases: A Systemic Review

Endeshaw Chekol Abebe et al.

Summary: Regulatory B cells (Bregs) are a novel subset of B cells that expand after activation upon specific stimuli, exerting negative immune regulatory roles and playing various roles in immune regulation, with potential pathological and protective effects in health and disease.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Article Cell Biology

The Effect of IL-35 on the Expression of Nasal Epithelial-Derived Proinflammatory Cytokines

Mingrong Nie et al.

Summary: The study revealed that IL-35 inhibited the secretion of various proinflammatory cytokines from nasal epithelial cells, playing an important role in the development of allergic rhinitis.

MEDIATORS OF INFLAMMATION (2021)

Review Immunology

Immunosuppressive Mechanisms of Regulatory B Cells

Diego Catalan et al.

Summary: Regulatory B cells play a crucial role in maintaining immune tolerance and preventing exacerbated inflammatory responses. In addition to IL-10, other molecules such as IL-35, TGF-beta, and cell surface proteins like CD1d and PD-L1 are utilized by Bregs to regulate immune responses.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment

Kewei Liu et al.

Summary: IL-35, a heterodimeric cytokine, plays important roles in the tumor microenvironment by promoting tumor growth, metastasis, and exhibiting immunosuppressive activity. Regulating immune cells can impact tumor-related phenotypes, and targeting IL-35 may offer potential strategies for inhibiting tumor growth.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell Biology

Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis

Hidaya A. Kader et al.

Summary: Atopic dermatitis (AD) is a prevalent inflammatory disease affecting up to one fifth of the population in developed countries, characterized by itching and eczema. It can lead to secondary allergies such as allergic rhinitis and asthma. The complex pathophysiology involves genetic predisposition, disrupted epidermal barrier, and immune dysregulation, with current management strategies limited to symptomatic treatment.

CELLS (2021)

Article Biochemistry & Molecular Biology

The role and correlation of IL-35 and type II intrinsic lymphocytes in children with allergic rhinitis

Ligao Huang et al.

Summary: IL-35 and ILC2 are significantly correlated with the severity of allergic rhinitis in children. IL-35 is negatively correlated with, while ILC2 is positively correlated with the severity of the condition. Detection of these indicators can aid in clinical diagnosis.

CELLULAR AND MOLECULAR BIOLOGY (2021)

Article Otorhinolaryngology

IL-35 Inhibited Th17 Response in Children with Allergic Rhinitis

Fengmei Xie et al.

ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY (2020)

Review Allergy

Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses

Saeko Nakajima et al.

ALLERGOLOGY INTERNATIONAL (2020)

Article Allergy

In vitro Conversion into CD4+CD25+Foxp3+ Induced Regulatory T Cells Is Reduced in Atopic Dermatitis Patients

Eva-Maria Garcia et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)

Article Criminology & Penology

Settled immigrants in the city of Malaga: local host context and crime

Elisa Garcia-Espana et al.

INTERNATIONAL E-JOURNAL OF CRIMINAL SCIENCES (2020)

Article Allergy

Role of IL-35 in sublingual allergen immunotherapy

Mohamed H. Shamji et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Letter Dermatology

IL-10-Producing Regulatory B Cells Are Decreased in Patients with Atopic Dermatitis

Yuki Yoshihara et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)

Review Allergy

Atopic dermatitis endotypes and implications for targeted therapeutics

Tali Czarnowicki et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Medicine, General & Internal

Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity

Yuxuan Li et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2019)

Article Allergy

Pathophysiology of atopic dermatitis: Clinical implications

Jihyun Kim et al.

ALLERGY AND ASTHMA PROCEEDINGS (2019)

Letter Allergy

Decreased interleukin-35 serum levels in patients with chronic spontaneous urticaria

Tao Chen et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)

Review Immunology

Emerging role of IL-35 in inflammatory autoimmune diseases

Lin-Chong Su et al.

AUTOIMMUNITY REVIEWS (2018)

Review Biochemistry & Molecular Biology

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis

Ramatu Omenesa Bello et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biotechnology & Applied Microbiology

Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α

Na-Na Tao et al.

JOURNAL OF GENERAL VIROLOGY (2018)

Article Medicine, General & Internal

IL-35-producing B cells in gastric cancer patients

Ke Wang et al.

MEDICINE (2018)

Article Immunology

Clinical significance of weak interleukin-35 expression in patients with psoriasis

Tengda Li et al.

MICROBIOLOGY AND IMMUNOLOGY (2018)

Review Allergy

The role of regulatory B cells in allergen immunotherapy

Willem van de Veen

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Review Immunology

Innate lymphoid cells: major players in inflammatory diseases

Mikael Ebbo et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Immunology

IL-12 FAMILY CYTOKINES: GENERAL CHARACTERISTICS, PATHOGENIC MICROORGANISMS, RECEPTORS, AND SIGNALLING PATHWAYS

Payam Behzadi et al.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2016)

Article Immunology

A Soluble Form of IL-27Rα Is a Natural IL-27 Antagonist

Celine Dietrich et al.

JOURNAL OF IMMUNOLOGY (2014)

Article Dermatology

IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models

Saeko Nakajima et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Article Dermatology

The Imbalance of Th17 cells and CD4+CD25highFoxp3+ Treg cells in patients with atopic dermatitis

L. Ma et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)

Article Cell Biology

The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease

Yanmei Li et al.

MEDIATORS OF INFLAMMATION (2014)

Article Immunology

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis

Maryam Salimi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Cell Biology

TSLP Elicits IL-33-Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation

Brian S. Kim et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Immunology

The composition and signaling of the IL-35 receptor are unconventional

Lauren W. Collison et al.

NATURE IMMUNOLOGY (2012)

Review Immunology

IL-12 family cytokines: immunological playmakers

Dario A. A. Vignali et al.

NATURE IMMUNOLOGY (2012)

Review Cell Biology

gp130 at the nexus of inflammation, autoimmunity, and cancer

J. S. Silver et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2010)

Article Immunology

IL-35-mediated induction of a potent regulatory T cell population

Lauren W. Collison et al.

NATURE IMMUNOLOGY (2010)

Article Allergy

Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis

Yasunori Ito et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2009)

Review Biochemistry & Molecular Biology

Regulatory T cells and immune tolerance

Shimon Sakaguchi et al.

Article Immunology

Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORγt

Jianfei Yang et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)

Article Immunology

Human CD4+CD25+Foxp3+ Regulatory T Cells Do Not Constitutively Express IL-35

Emilie Bardel et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Multidisciplinary Sciences

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Lauren W. Collison et al.

NATURE (2007)

Article Allergy

Absence of T-regulatory cell expression and function in atopic dermatitis skin

J Verhagen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)

Article Biochemistry & Molecular Biology

Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes

N Takahashi et al.

HUMAN MOLECULAR GENETICS (2005)